Complete Filing Data
Capstone Holding Corp. reported Cash And Cash Equivalents At Carrying Value of $52.0 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Capstone Holding Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.6M | -$3.8M | $380.0K | $1.8M | -$663.0K | -$2.8M | -$4.2M | -$3.9M | -$3.6M | -$9.7M | $10.9M |
| Revenue * | $45.8M | $48.6M | -$2.0M | $0.00 | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.1M | -$3.6M | $432.0K | $1.8M | -$1.7M | -$3.0M | -$4.6M | -$4.1M | -$4.1M | -$9.9M | $11.1M |
| Income Tax Expense Benefit | $442.0K | $234.0K | $52.0K | $36.0K | -$56.0K | -$192.0K | -$400.0K | -$21.0K | $0.00 | -$158.0K | $181.0K |
| Research And Development Expense Excluding Acquired In Process Cost | $1.4M | $1.0M | $1.0M | $1.2M | $3.1M | $3.1M | $2.4M | $6.4M | $8.2M | ||
| Operating Expenses | $2.2M | $1.7M | $1.6M | $2.9M | $4.5M | $4.3M | $4.1M | $9.9M | $11.4M | ||
| General And Administrative Expense | $554.0K | $641.0K | $543.0K | $1.8M | $1.5M | $1.2M | $1.8M | $3.5M | $3.2M | ||
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | -$946.0K | $0.00 | $0.00 | -$193.0K | -$473.0K | $0.00 | |||
| Other Nonoperating Income Expense | $143.0K | $251.0K | $111.0K | -$81.0K | -$24.0K | -$43.0K | |||||
| Research And Development In Process | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Income Loss From Continuing Operations | -$4.1M | -$4.1M | -$9.7M | $10.9M | |||||||
| Deferred Income Tax Expense Benefit | $419.0K | $32.0K | $0.00 | $0.00 | $0.00 | ||||||
| Operating Income Loss | -$638.0K | -$1.3M | $181.0K | $1.7M | |||||||
| Selling General And Administrative Expense | $10.2M | $10.9M | |||||||||
| Sales Returns And Allowances | $932.0K | $289.0K | |||||||||
| Cost Of Revenue | $35.3M | $38.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.0M | -$700.0K | -$1.7M | $34.0K | -$381.0K | -$1.1M | -$668.0K | -$855.0K | -$693.0K | $1.3M | -$587.0K | -$598.0K | -$206.0K | -$387.0K | $459.0K | -$390.0K | -$379.0K | -$435.0K | -$752.0K | -$716.0K | -$1.2M | -$1.4M | -$1.0M | -$1.2M | -$1.0M | -$995.0K | -$951.0K | -$712.0K | -$976.0K | $1.6M | -$2.2M | -$3.2M | $2.6M | $2.9M |
| Revenue * | $14.0M | $13.2M | $8.2M | $12.6M | $13.2M | $9.6M | $0.00 | $0.00 | $0.00 | $2.0M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.0M | -$700.0K | -$1.7M | $39.0K | -$380.0K | -$1.1M | -$668.0K | -$852.0K | -$693.0K | $1.3M | -$590.0K | -$606.0K | -$208.0K | -$395.0K | -$521.0K | -$402.0K | -$393.0K | -$435.0K | -$788.0K | -$878.0K | -$1.2M | -$1.4M | -$1.0M | -$1.2M | -$1.0M | -$1.2M | -$1.1M | -$712.0K | $976.0K | $1.6M | $2.2M | $3.2M | $2.6M | |
| Income Tax Expense Benefit | $5.0K | $1.0K | $16.0K | $0.00 | $3.0K | $0.00 | $0.00 | -$3.0K | -$8.0K | -$2.0K | -$8.0K | -$34.0K | -$12.0K | -$14.0K | $0.00 | -$36.0K | -$162.0K | $0.00 | $0.00 | $0.00 | $0.00 | -$21.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Research And Development Expense Excluding Acquired In Process Cost | $427.0K | $601.0K | $507.0K | $322.0K | $301.0K | $386.0K | $112.0K | $267.0K | $446.0K | $220.0K | $157.0K | $175.0K | $283.0K | $350.0K | $865.0K | $1.2M | $630.0K | $958.0K | $749.0K | $912.0K | $667.0K | $403.0K | $556.0K | $1.2M | $1.4M | $2.1M | $1.9M | $2.2M | ||||||
| Operating Expenses | $605.0K | $789.0K | $633.0K | $660.0K | $530.0K | $545.0K | $214.0K | $380.0K | $501.0K | $377.0K | $382.0K | $416.0K | $835.0K | $822.0K | $1.2M | $1.4M | $1.1M | $1.2M | $1.0M | $1.3M | $1.1M | $796.0K | $980.0K | $1.6M | $2.2M | $3.2M | $2.6M | $2.9M | ||||||
| General And Administrative Expense | $178.0K | $188.0K | $126.0K | $84.0K | $229.0K | $159.0K | $102.0K | $113.0K | $55.0K | $157.0K | $225.0K | $241.0K | $552.0K | $472.0K | $373.0K | $222.0K | $452.0K | $245.0K | $277.0K | $433.0K | $480.0K | $393.0K | $424.0K | $391.0K | $797.0K | $1.2M | $698.0K | $789.0K | ||||||
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$946.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$193.0K | -$191.0K | $0.00 | $0.00 | |||||||||||
| Other Nonoperating Income Expense | -$63.0K | -$63.0K | -$60.0K | -$62.0K | -$60.0K | -$61.0K | $6.0K | -$15.0K | -$20.0K | -$25.0K | -$11.0K | -$19.0K | $47.0K | -$56.0K | $4.0K | $3.0K | $60.0K | |||||||||||||||||
| Research And Development In Process | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Income Loss From Continuing Operations | -$1.4M | -$1.0M | -$1.2M | -$1.0M | -$1.2M | -$1.1M | -$712.0K | $976.0K | $1.6M | $2.2M | $3.2M | $2.6M | $2.9M | |||||||||||||||||||||
| Deferred Income Tax Expense Benefit | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||
| Operating Income Loss | -$768.0K | -$260.0K | -$1.4M | $413.0K | $14.0K | -$717.0K | -$605.0K | -$789.0K | -$633.0K | $1.3M | -$530.0K | -$545.0K | -$214.0K | |||||||||||||||||||||
| Selling General And Administrative Expense | $3.4M | $3.4M | $2.8M | $2.6M | $2.8M | $2.5M | ||||||||||||||||||||||||||||
| Sales Returns And Allowances | $336.0K | $341.0K | $266.0K | $241.0K | $265.0K | $224.0K | ||||||||||||||||||||||||||||
| Cost Of Revenue | $10.4M | $9.7M | $6.6M | $9.3M | $10.1M | $7.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $8.2M | -$879.0K | -$122.0K | $506.0K | $3.1M | $7.2M | $11.1M | $14.6M | $7.9M | $34.7M | $118.4M | ||
| Cash And Cash Equivalents At Carrying Value | $52.0K | $698.0K | $1.0M | $2.2M | $6.3M | $10.2M | $13.8M | $24.4M | $12.9M | ||||
| Cash And Cash Equivalents Period Increase Decrease | $66.0K | $577.0K | -$313.0K | -$1.2M | -$4.1M | -$3.9M | -$3.6M | -$10.6M | $11.5M | ||||
| Retained Earnings Accumulated Deficit | -$190.6M | -$191.4M | -$189.6M | -$189.0M | -$186.2M | -$182.0M | -$178.1M | -$174.5M | -$180.4M | ||||
| Liabilities Current | $16.0M | $199.0K | $304.0K | $261.0K | $282.0K | $100.0K | $294.0K | $119.0K | $1.8M | ||||
| Liabilities And Stockholders Equity | $52.7M | $1.6M | $1.2M | $1.8M | $3.4M | $7.3M | $11.6M | $14.7M | $25.3M | ||||
| Assets Current | $17.1M | $1.4M | $829.0K | $1.3M | $2.7M | $6.5M | $10.6M | $14.5M | $25.0M | ||||
| Assets | $52.7M | $1.6M | $1.2M | $1.8M | $3.4M | $7.3M | $11.6M | $14.7M | $25.3M | ||||
| Accrued Liabilities Current | $324.0K | $2.0K | $55.0K | $7.0K | $158.0K | $12.0K | $61.0K | $29.0K | $236.0K | ||||
| Accounts Payable Current | $2.6M | $197.0K | $249.0K | $254.0K | $124.0K | $88.0K | $233.0K | $77.0K | $246.0K | ||||
| Common Stock Value | $27.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | |||||
| Other Assets Current | $241.0K | $98.0K | $131.0K | $247.0K | $555.0K | $233.0K | $383.0K | $758.0K | |||||
| Additional Paid In Capital Common Stock | $190.5M | $189.5M | $189.4M | $189.3M | $189.2M | $189.2M | $189.1M | $188.3M | |||||
| Property Plant And Equipment Net | $1.8M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.0K | $23.0K | $160.0K | $258.0K | |||
| Minority Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $193.0K | $0.00 | ||||||
| Finite Lived Intangible Assets Net | $196.0K | $353.0K | $509.0K | $666.0K | $823.0K | $980.0K | $0.00 | ||||||
| Convertible Long Term Notes Payable | $0.00 | $1.0M | $1.0M | $0.00 | |||||||||
| Secured Long Term Debt | $2.2M | $0.00 | |||||||||||
| Long Term Debt Noncurrent | $5.1M | $2.5M | $2.2M | $1.0M | |||||||||
| Employee Related Liabilities Current | $6.0K | $13.0K | $674.0K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $23.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 | Q3 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $27.2M | $26.3M | $27.0M | -$3.1M | -$1.9M | -$925.0K | $403.0K | $2.4M | -$2.8M | -$2.1M | -$1.2M | -$870.0K | -$182.0K | -$1.5M | -$315.0K | -$715.0K | -$509.0K | $228.0K | -$231.0K | $147.0K | $1.4M | $1.8M | $2.4M | $3.6M | $4.9M | $6.2M | $7.9M | $9.1M | $12.0M | $13.0M | $13.6M | $17.2M | $18.8M | ||||||
| Cash And Cash Equivalents At Carrying Value | $730.0K | $773.0K | $1.7M | $11.0K | $305.0K | $1.1M | $1.3M | $1.8M | $2.3M | $805.0K | $1.3M | $1.7M | $437.0K | $486.0K | $1.1M | $692.0K | $718.0K | $637.0K | $1.0M | $1.5M | $3.1M | $4.2M | $5.5M | $7.2M | $8.1M | $9.2M | $11.4M | $12.8M | $13.1M | $17.6M | $19.6M | $21.6M | $11.7M | $9.1M | $55.4M | ||||
| Cash And Cash Equivalents Period Increase Decrease | -$249.0K | -$470.0K | -$212.0K | -$293.0K | -$624.0K | -$768.0K | -$1.0M | -$661.0K | -$2.7M | ||||||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$201.2M | -$199.2M | -$198.5M | -$196.1M | -$193.3M | -$192.6M | -$191.8M | -$191.4M | -$190.7M | -$192.0M | -$190.8M | -$190.2M | -$190.0M | -$189.3M | -$189.7M | -$189.3M | -$188.1M | -$187.7M | -$186.9M | -$185.7M | -$184.4M | -$183.0M | -$181.3M | -$180.1M | -$177.2M | -$176.2M | -$175.5M | -$171.8M | -$170.2M | ||||||||||
| Liabilities Current | $20.0M | $17.0M | $14.7M | $12.6M | $819.0K | $732.0K | $246.0K | $417.0K | $247.0K | $206.0K | $193.0K | $1.5M | $391.0K | $369.0K | $431.0K | $266.0K | $188.0K | $351.0K | $365.0K | $471.0K | $430.0K | $288.0K | $206.0K | $101.0K | $214.0K | $93.0K | $156.0K | $764.0K | $1.2M | ||||||||||
| Liabilities And Stockholders Equity | $58.5M | $51.9M | $52.2M | $47.2M | $703.0K | $1.2M | $1.5M | $2.0M | $2.4M | $1.0M | $2.0M | $758.0K | $882.0K | $1.6M | $1.2M | $1.4M | $1.5M | $2.1M | $2.8M | $4.1M | $5.3M | $6.5M | $8.1M | $9.2M | $12.7M | $13.1M | $13.8M | $18.0M | $20.0M | ||||||||||
| Assets Current | $19.1M | $16.5M | $16.7M | $12.8M | $703.0K | $1.2M | $1.4M | $1.9M | $2.3M | $881.0K | $1.8M | $484.0K | $568.0K | $1.2M | $769.0K | $943.0K | $997.0K | $1.5M | $2.2M | $3.4M | $4.5M | $5.7M | $7.3M | $8.3M | $11.7M | $13.0M | $13.6M | $17.8M | $19.8M | ||||||||||
| Assets | $58.5M | $51.9M | $52.2M | $47.2M | $703.0K | $1.2M | $1.5M | $2.0M | $2.4M | $1.0M | $2.0M | $758.0K | $882.0K | $1.6M | $1.2M | $1.4M | $1.5M | $2.1M | $2.8M | $4.1M | $5.3M | $6.5M | $8.1M | $9.2M | $12.7M | $13.1M | $13.8M | $18.0M | $20.0M | ||||||||||
| Accrued Liabilities Current | $1.3M | $923.0K | $747.0K | $394.0K | $22.0K | $102.0K | $1.0K | $2.0K | $3.0K | $3.0K | $36.0K | $80.0K | $67.0K | $44.0K | $29.0K | $93.0K | $56.0K | $140.0K | $180.0K | $246.0K | $318.0K | $35.0K | $6.0K | $27.0K | $4.0K | $5.0K | $2.0K | $38.0K | $140.0K | ||||||||||
| Accounts Payable Current | $5.5M | $3.6M | $4.4M | $3.3M | $797.0K | $630.0K | $245.0K | $415.0K | $244.0K | $203.0K | $157.0K | $393.0K | $324.0K | $325.0K | $402.0K | $173.0K | $132.0K | $211.0K | $185.0K | $225.0K | $112.0K | $253.0K | $200.0K | $74.0K | $209.0K | $81.0K | $144.0K | $337.0K | $385.0K | ||||||||||
| Common Stock Value | $3.0K | $3.0K | $3.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | |||||||||||
| Other Assets Current | $242.0K | $242.0K | $242.0K | $242.0K | $398.0K | $129.0K | $97.0K | $68.0K | $11.0K | $76.0K | $84.0K | $47.0K | $82.0K | $78.0K | $77.0K | $225.0K | $360.0K | $509.0K | $631.0K | $277.0K | $345.0K | $235.0K | $83.0K | $197.0K | $330.0K | $200.0K | $532.0K | ||||||||||||
| Additional Paid In Capital Common Stock | $190.5M | $190.5M | $190.5M | $190.5M | $190.5M | $190.5M | $190.5M | $189.5M | $189.5M | $189.5M | $189.5M | $189.5M | $189.4M | $189.4M | $189.3M | $189.3M | $189.3M | $189.2M | $189.2M | $189.2M | $189.2M | $189.2M | $189.1M | $189.0M | $189.0M | ||||||||||||||
| Property Plant And Equipment Net | $1.7M | $1.5M | $1.5M | $1.6M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.0K | $5.0K | $7.0K | $28.0K | $34.0K | $136.0K | $187.0K | $214.0K | |||||||||||||||||
| Minority Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $477.0K | ||||||||||||||||||
| Finite Lived Intangible Assets Net | $0.00 | $0.00 | $39.0K | $78.0K | $118.0K | $157.0K | $235.0K | $274.0K | $314.0K | $392.0K | $431.0K | $470.0K | $549.0K | $588.0K | $627.0K | $705.0K | $745.0K | $784.0K | $862.0K | $902.0K | $1.0M | ||||||||||||||||||
| Convertible Long Term Notes Payable | $0.00 | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | |||||||||||||||||||||||||||||||||
| Secured Long Term Debt | $2.6M | $2.6M | $2.5M | $2.4M | $2.4M | $2.3M | $2.2M | ||||||||||||||||||||||||||||||||
| Long Term Debt Noncurrent | $7.2M | $5.8M | $7.5M | $6.3M | $2.2M | ||||||||||||||||||||||||||||||||||
| Employee Related Liabilities Current | $1.0K | $7.0K | $10.0K | $389.0K | $637.0K | ||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $730.0K | $773.0K | $1.7M | $11.0K | $13.0K | $30.0K | $51.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$3.7M | -$1.4M | $0.00 | $2.1M | $946.0K | $1.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Investing Cash Flow * | -$120.0K | -$208.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.0K | -$206.0K | -$19.0K | $22.2M |
| Operating Cash Flow * | $3.8M | $1.7M | $66.0K | -$1.6M | -$1.3M | -$2.2M | -$4.1M | -$4.0M | -$3.4M | -$10.6M | -$10.7M |
| Share Based Compensation | $15.0K | $0.00 | $35.0K | $174.0K | $53.0K | $34.0K | $107.0K | $159.0K | $275.0K | ||
| Increase Decrease In Accounts Payable | $48.0K | -$52.0K | -$5.0K | $130.0K | $36.0K | -$145.0K | $156.0K | -$169.0K | -$473.0K | ||
| Depreciation Depletion And Amortization | $179.0K | $157.0K | $160.0K | $173.0K | $29.0K | $117.0K | $135.0K | ||||
| Proceeds From Issuance Of Common Stock | $0.00 | $1.0M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Payments To Acquire Property Plant And Equipment | $120.0K | $208.0K | $0.00 | $0.00 | $19.0K | $60.0K | |||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $4.0K | $172.0K | $0.00 | $0.00 | ||||||
| Increase Decrease In Other Current Assets | -$1.0K | -$26.0K | -$93.0K | -$308.0K | $322.0K | -$150.0K | |||||
| Increase Decrease In Other Accrued Liabilities | -$13.0K | -$53.0K | $48.0K | -$151.0K | $146.0K | -$49.0K | |||||
| Increase Decrease In Interest Income Taxes And Other Current Assets | -$150.0K | -$375.0K | $115.0K | -$1.0M | |||||||
| Increase Decrease In Accrued Liabilities | -$49.0K | $19.0K | -$871.0K | -$778.0K | |||||||
| Payments To Acquire Intangible Assets | $0.00 | $378.0K | $0.00 | $0.00 | |||||||
| Proceeds From Stock Options Exercised | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Proceeds From Sale And Maturity Of Held To Maturity Securities | $0.00 | $0.00 | $0.00 | $47.4M | |||||||
| Payments To Acquire Held To Maturity Securities | $0.00 | $0.00 | $0.00 | $25.1M | |||||||
| Payments For Repurchase Of Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Proceeds From Repayments Of Notes Payable | $0.00 | -$1.0M | $0.00 | $1.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $4.0M | $1.3M | $50.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Investing Cash Flow * | -$100.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.0K | $0.00 | $0.00 | |
| Operating Cash Flow * | -$2.3M | -$1.2M | -$299.0K | -$470.0K | -$212.0K | -$293.0K | -$624.0K | -$768.0K | -$1.0M | -$661.0K | -$2.7M |
| Share Based Compensation | $4.0K | $2.0K | $0.00 | $20.0K | $46.0K | $28.0K | $17.0K | $28.0K | $67.0K | ||
| Increase Decrease In Accounts Payable | $385.0K | $6.0K | $75.0K | -$81.0K | $61.0K | $165.0K | $80.0K | $67.0K | $386.0K | ||
| Depreciation Depletion And Amortization | $39.0K | $44.0K | $45.0K | $39.0K | $40.0K | $45.0K | $24.0K | $32.0K | |||
| Proceeds From Issuance Of Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Payments To Acquire Property Plant And Equipment | $100.0K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $4.0K | $0.00 | $0.00 | |||||||
| Increase Decrease In Other Current Assets | $5.0K | -$10.0K | -$44.0K | -$16.0K | $76.0K | $2.0K | |||||
| Increase Decrease In Other Accrued Liabilities | $74.0K | $1.0K | $12.0K | $86.0K | $22.0K | $23.0K | |||||
| Increase Decrease In Interest Income Taxes And Other Current Assets | $2.0K | -$78.0K | -$226.0K | -$180.0K | |||||||
| Increase Decrease In Accrued Liabilities | $23.0K | -$40.0K | -$30.0K | -$175.0K | |||||||
| Payments To Acquire Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Proceeds From Stock Options Exercised | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Proceeds From Sale And Maturity Of Held To Maturity Securities | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Payments To Acquire Held To Maturity Securities | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Payments For Repurchase Of Common Stock | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Payments To Acquire Businesses Net Of Cash Acquired | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Proceeds From Repayments Of Notes Payable |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$34.87 | -$36.39 | -$0.01 | -$0.04 | $0.02 | $0.07 | $0.10 | $0.10 | $0.09 | $0.24 | $0.27 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 54.4K | 47.2K | 40.9M | 40.9M | 40.9M | 40.9M | 40.9K | 40.8K | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 200.0K | 150.0M | 150.0M | 150.0M | 150.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Common Stock Shares Outstanding | 54.4M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.8M | 40.8M | 41.8M | |||
| Common Stock Shares Issued | 157.6K | 40.9M | 40.9M | 40.8M | 40.8M | |||||||
| Weighted Average Number Of Basic And Diluted Shares Outstanding | 40.8M | 40.8M | ||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 157.6K | 157.6K | ||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 157.6K | 157.6K | ||||||||||
| Earnings Per Share Basic | $-34.87 | $-36.39 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.35 | -$0.13 | -$0.47 | -$6.33 | -$8.43 | -$12.91 | -$0.01 | -$0.02 | -$0.01 | $0.02 | -$0.01 | -$0.01 | -$0.01 | $0.01 | -$0.01 | $0.01 | $0.01 | $0.01 | $0.02 | $0.02 | $0.03 | $0.03 | $0.02 | $0.03 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | $0.04 | $0.05 | $0.08 | $0.06 | $0.07 | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 54.4K | 54.4K | 54.4M | 54.4K | 54.4K | 52.3M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9K | 40.9M | 40.9K | 40.9K | 40.8K | ||||||||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 200.0K | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | ||||||||||
| Common Stock Shares Outstanding | 54.4M | 54.4M | 54.4M | 54.4M | 54.4M | 54.4M | 54.4M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.8M | 40.8M | ||||||||||||||
| Common Stock Shares Issued | 6.3M | 5.4M | 5.2M | 157.6K | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.9M | 40.8M | 40.8M | |||||||||||||||||
| Weighted Average Number Of Basic And Diluted Shares Outstanding | 40.9K | 40.9M | 40.8M | 40.8K | 40.8M | 40.8M | 40.8M | ||||||||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 5.7M | 5.4M | 5.2M | 157.6K | 157.6K | 157.6K | |||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 5.7M | 5.4M | 5.2M | 157.6K | 157.6K | 157.6K | |||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.35 | $-0.13 | $-0.47 | $-6.33 | $-8.43 | $-12.91 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|
| Interest And Other Income | -$43.0K | $158.0K | $96.0K | $31.0K | -$356.0K | ||||
| Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Gain Loss On Sale Of Business | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Other General Expense | $0.00 | $0.00 | |||||||
| Other Operating Income | $0.00 | $0.00 | $0.00 | ||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $150.3M | $146.8M | $152.6M | ||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $15.0K | $0.00 | $35.0K | $174.0K | $53.0K | $34.0K | $107.0K | $159.0K | $156.0K |
| Sublicense Transaction Costs | $254.0K | $0.00 | |||||||
| Other Noncash Expense | $238.0K | $68.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest And Other Income | $4.0K | $3.0K | $60.0K | $1.0K | -$3.0K | $157.0K | $5.0K | $84.0K | -$4.0K | -$2.0K | -$4.0K | -$10.0K | -$28.0K | -$26.0K | |||||||||
| Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Gain Loss On Sale Of Business | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||||
| Other General Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Other Operating Income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $156.7M | $155.3M | $154.3M | $153.5M | $152.3M | $149.4M | $148.4M | $147.7M | $144.1M | $142.5M | |||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | |||||||||||||||||||||||
| Sublicense Transaction Costs | $0.00 | $0.00 | $0.00 | $254.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||
| Other Noncash Expense | $59.0K | $59.0K | $0.00 |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.